You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 9,556,452


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,556,452
Title:Vaccine for control of beet curly top virus infection of plants
Abstract: The disclosure provides plant vaccine compositions and methods for inducing immunity to Beet Curly Top Virus (BCTV) and related curtoviruses in a susceptible plant.
Inventor(s): Wintermantel; William M (Salinas, CA), Hladky; Laura L (Salinas, CA)
Assignee: The United States of America, as Represented by the Secretary of Agriculture (Washington, DC)
Application Number:14/037,750
Patent Claims:1. A plant vaccine composition for inducing immunity to Beet Curly Top Virus (BCTV) in a susceptible plant, the plant vaccine comprising: an expression vector comprising a heterologous promoter sequence operably linked to an isolated BCTV vaccine nucleic acid sequence that is selected from the group consisting of (i) SEQ ID NO:14 and (ii) both SEQ ID NO:10 and SEQ ID NO:11.

2. A plant vaccine composition for inducing immunity to Beet Curly Top Virus (BCTV) in a susceptible plant, the plant vaccine comprising: an expression vector comprising a heterologous promoter operably linked to SEQ ID NO:10 wherein SEQ ID NO:10 is operably linked to an intron, and the intron is operably linked to SEQ ID NO:11.

3. The plant vaccine composition of claim 1, wherein the vaccine induces immunity to Beet Curly Top Viruses that are members selected from the group consisting of Beet Severe Curly Top Virus (BSCTV) and Beet Mild Curly Top Virus (BMCTV).

4. The plant vaccine composition of claim 1, wherein the susceptible plant is a member selected from the group consisting of sugar beet (Beta vulgaris), tomato (Solanum lycopersicum), bean (Phaseolus vulgaris), and pepper (Capsicum spp.).

5. The plant vaccine composition of claim 4, wherein the susceptible plant is sugar beet.

6. The plant vaccine composition of claim 4, wherein the susceptible plant is tomato.

7. A method for inducing immunity to Beet Curly Top Virus (BCTV) in a susceptible plant, thereby protecting the susceptible plant from infection with BCTV, the method comprising: (i) transfecting the susceptible plant with a suspension of Agrobacterium tumefaciens, wherein the Agrobacterium tumefaciens comprises an expression vector comprising a heterologous promoter operably linked to an isolated BCTV vaccine nucleic acid sequence that is selected from the group consisting of (i) SEQ ID NO:14 and (ii) the combination of SEQ ID NO:10 and SEQ ID NO:11, to generate a transformed plant; and (ii) selecting said transformed plant that expresses said isolated BCTV vaccine nucleic acid sequence to produce a vaccinated plant; wherein expression of the isolated BCTV vaccine nucleic acid sequence in the vaccinated plant induces silencing of the BCTV, thereby protecting the susceptible plant from infection with BCTV.

8. A method for inducing immunity to Beet Curly Top Virus (BCTV) in a susceptible plant, thereby protecting the susceptible plant from infection with BCTV, the method comprising: (i) transfecting the susceptible plant with a suspension of Agrobacterium tumefaciens, wherein the Agrobacterium tumefaciens comprises an expression vector comprising a heterologous promoter operably linked to SEQ ID NO:10 wherein SEQ ID NO:10 is operably linked to an intron, and the intron is operably linked to SEQ ID NO:11 to generate a transformed plant, (ii) selecting said transformed plant that expresses said SEQ ID NO:10, intron and SEQ ID NO:11 to produce a vaccinated plant; wherein expression of the expression vector in the vaccinated plant induces silencing of the BCTV thereby protecting the susceptible plant from infection with BCTV.

9. The method of claim 7, wherein the transfection is transient transfection.

10. The method of claim 9, wherein transient transfection is carried out by direct injection of the suspension of Agrobacterium tumefaciens into a stem of the susceptible plant.

11. The method of claim 9, wherein transient transfection comprises spraying the suspension of Agrobacterium tumefaciens onto one or more leaves of the susceptible plant.

12. The method of claim 7, wherein the method induces immunity to Beet Curly Top Viruses that are members selected from the group consisting of Beet Severe Curly Top Virus (BSCTV) and Beet Mild Curly Top Virus (BMCTV).

13. The method of claim 7, wherein the susceptible plant is a member selected from the group consisting of sugar beet (Beta vulgaris), tomato (Solanum lycopersicum), bean (Phaseolus vulgaris), and pepper (Capsicum spp.).

14. The method of claim 13, wherein the susceptible plant is sugar beet.

15. The method of claim 13, wherein the susceptible plant is tomato.

16. A transformed plant comprising an expression vector wherein said expression vector comprises a heterologous promoter operably linked to a nucleic acid selected from the group consisting of (i) SEQ ID NO:14 and (ii) both SEQ ID NO:10 and SEQ ID NO:11.

17. The transformed plant of claim 16, wherein said plant is selected from the group consisting of sugar beet (Beta vulgaris), tomato (Solanum lycopersicum), bean (Phaseolus vulgaris), and pepper (Capsicum spp.).

18. The method of claim 8, wherein the transfection is transient transfection.

19. The method of claim 18, wherein transient transfection is carried out by direct injection of the suspension of Agrobacterium tumefaciens into a stem of the susceptible plant.

20. The method of claim 18, wherein transient transfection comprises spraying the suspension of Agrobacterium tumefaciens onto one or more leaves of the susceptible plant.

21. The method of claim 18 wherein said transient transfection comprises dipping said susceptible plant into said suspension of Agrobacterium tumefaciens.

22. The method of claim 9 wherein said transient transfection comprises dipping said susceptible plant into said suspension of Agrobacterium tumefaciens.

23. The plant vaccine composition of claim 1 further comprising a carrier.

24. The plant vaccine composition of claim 23, wherein said carrier comprises 2-(4-morpholine)-ethane sulfonic acid (MES), MgCl.sub.2 and acetosyringone.

25. The plant vaccine composition of claim 2 further comprising a carrier.

26. The plant vaccine composition of claim 25, wherein said carrier comprises MES, MgCl.sub.2 and acetosyringone.

27. The method of claim 7 wherein said suspension of Agrobacterium tumefaciens further comprises MES, MgCl.sub.2 and acetosyringone.

28. The method of claim 8 wherein said suspension of Agrobacterium tumefaciens further comprises MES, MgCl.sub.2 and acetosyringone.

Details for Patent 9,556,452

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2032-09-28
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2032-09-28
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2032-09-28
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.